Pandemic Flu News 

Bacteria Fingered As Killer In 1918 Flu Pandemic (NPR)
Found on 19 Aug 2008 22:28 GMT
Bacterial pneumonia attacked virus-weakened lungs and killed most of the 50 million victims of the 1918 flu pandemic. This finding may be good news should another flu pandemic strike, because doctors are now armed with effective treatments for bacterial infections.

Survivors of 1918 Flu Pandemic Immune 90 Years Later (MedicineNet.com)
Found on 19 Aug 2008 21:35 GMT
Title: Survivors of 1918 Flu Pandemic Immune 90 Years Later Category: Health News Created: 8/19/2008 2:00:00 AM Last Editorial Review: 8/19/2008

Bacteria a big killer in 1918 flu pandemic: study (MSNBC)
Found on 19 Aug 2008 19:34 GMT
Bacterial pneumonia may have killed most people during the 1918 flu pandemic, and antibiotics may be as crucial as flu drugs to fight any new pandemic, researchers say.

Bacteria a big killer in 1918 flu pandemic: study
Found on 19 Aug 2008 18:56 GMT
Bacterial pneumonia may have killed most people during the 1918 flu pandemic, and antibiotics may be as crucial as flu drugs to fight any new pandemic, U.S. researchers reported on Tuesday.

1918 pandemic antibodies could be effective against bird flu (New Kerala)
Found on 18 Aug 2008 18:48 GMT
Washington, Aug 18 (IANS) Researchers who isolated antibodies from the elderly survivors of the horrific 1918 flu pandemic, found that they could be equally effecitve against similar outbreaks in future.

Flu Antibodies Recovered From 1918 Pandemic Survivors (Medical News Today)
Found on 18 Aug 2008 12:17 GMT
Scientists in the US recovered antibodies to the 1918 flu virus from elderly survivors of the pandemic, used them to create cell lines of monoclonal antibodies and then showed they were still potent by injecting them into infected mice that survived, whereas the controls did not.

New strategy for flu pandemic (Albany Times Union)
Found on 18 Aug 2008 10:40 GMT
Bacterial infections killed most victims of 1918 flu, scientists say Most deaths in the 1918 influenza pandemic were caused not by the virus alone, but by common bacterial infections that overwhelmed victims' weakened immune systems, according to two new studies that could change the strategy against the next pandemic. "We have to realize that it isn't just antivirals that we need," said Dr....

Antibodies to 1918 flu pandemic may provide means to tackle bird flu threat (...
Found on 18 Aug 2008 09:11 GMT
Scientists in the United States have discovered that elderly survivors of the original 1918 flu pandemic, still have immunity to the virus.

Flu Antibodies Recovered From 1918 Pandemic Survivors
Found on 18 Aug 2008 08:59 GMT
Scientists in the US recovered antibodies to the 1918 flu virus from elderly survivors of the pandemic, used them to create cell lines of monoclonal antibodies and then showed they were still potent by injecting them into infected mice that survived, whereas the controls did not.

Survivors of 1918 Flu Pandemic Immune 90 Years Later (HealthCentral.com)
Found on 17 Aug 2008 21:02 GMT
Copyright © 2008 ScoutNews LLC. All rights reserved. SUNDAY, Aug. 17 (HealthDay News) - People who lived through the 1918 flu pandemic that killed 50 million worldwide are still producing antibodies to the virus 90 years later, researchers report.

Survivors of 1918 Flu Pandemic Immune 90 Years Later (HealthDay)
Found on 17 Aug 2008 20:00 GMT
SUNDAY, Aug. 17 (HealthDay News) - People who lived through the 1918 flu pandemic that killed 50 million worldwide are still producing antibodies to the virus 90 years later, researchers report.

Canopus Biopharma And Leading Chinese Researcher Team Up To Treat Avian Influ...
Found on 14 Aug 2008 11:59 GMT
An internationally renowned avian influenza expert hailed "encouraging and exciting" results from experiments conducted by his research team. This study demonstrated impressive efficacy of a novel statin/caffeine combination, StatC? in the treatment and prevention of H5N1, H1N1 and H3N2 in a mouse model. Dr.

Vical Announces Breakthrough For Pandemic Influenza DNA Vaccines With Prelimi...
Found on 18 Jul 2008 10:59 GMT
Vical Incorporated (Nasdaq: VICL) announced a breakthrough with preliminary clinical trial data demonstrating that DNA vaccines can safely achieve significant immune responses against H5N1 pandemic influenza in humans.

Indiana Health Officials Examine State's Pandemic Influenza Ethics Planning
Found on 18 Jul 2008 09:59 GMT
Information relevant to Indiana's current pandemic influenza preparedness plan was presented July 16 during a symposium convened by the Indiana State Department of Health and the Indiana University Center for Bioethics, "The Ethics of Pandemic Influenza Planning in Indiana: What Have We Done and

Possible Future Avian Influenza Pandemic May Be Eased By Booster Vaccination
Found on 17 Jul 2008 12:59 GMT
New evidence suggests that a booster vaccination against H5N1 avian influenza given years after initial vaccination with a different strain may prove useful in controlling a potential future pandemic. The study is published in the August 1 issue of The Journal of Infectious Diseases, now available online. H5N1 continues to pose a major health risk to birds and humans.

Vical To Present Phase 1 Data For Vaxfectin(R)-Formulated Pandemic Influenza ...
Found on 15 Jul 2008 09:59 GMT
Vical Incorporated (Nasdaq: VICL) announced the scheduled presentation of preliminary human safety and immunogenicity data from a Phase 1 trial of the company's Vaxfectin(R)-formulated H5N1 pandemic influenza DNA vaccines on Thursday, July 17, at the IBC Life Sciences Next Generation Vaccines conference (National Harbor, MD - July 17-18). Vical's Vice President of ...

Report Offers Resources For Home Health Care Response During A Flu Pandemic
Found on 09 Jul 2008 09:59 GMT
Home Health Care During an Influenza Pandemic: Issues and Resources, a report identifying home health care as a critical component in providing care during a pandemic influenza event and offering resources to home health care providers and community planners to prepare for such an event, was released today by the U.S.

Sinovac Initiates Phase II Volunteer Enrollment For Split Viron Pandemic Infl...
Found on 01 Jul 2008 09:59 GMT
Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, announced the initiation of volunteer enrollment in its Phase II clinical trial for its split pandemic influenza vaccine. The preliminary results from this study are expected to be available in early 2009.